In last trading session, iBio Inc (NASDAQ:IBIO) saw 0.3 million shares changing hands with its beta currently measuring 0.92. Company’s recent per share price level of $5.08 trading at -$0.05 or -0.97% at ring of the bell on the day assigns it a market valuation of $50.17M. That closing price of IBIO’s stock is at a discount of -35.63% from its 52-week high price of $6.89 and is indicating a premium of 79.33% from its 52-week low price of $1.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.64 million shares which gives us an average trading volume of 443.38K if we extend that period to 3-months.
For iBio Inc (IBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.32 in the current quarter.
iBio Inc (NASDAQ:IBIO) trade information
Upright in the red during last session for losing -0.97%, in the last five days IBIO remained trading in the red while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $5.08 price level, adding 13.16% to its value on the day. iBio Inc’s shares saw a change of 107.35% in year-to-date performance and have moved -9.29% in past 5-day. iBio Inc (NASDAQ:IBIO) showed a performance of 38.04% in past 30-days. Number of shares sold short was 0.45 million shares which calculate 1.44 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3.6 to the stock, which implies a fall of -41.11% to its current value. Analysts have been projecting 3.6 as a low price target for the stock while placing it at a high target of 3.6. It follows that stock’s current price would jump 29.13% in reaching the projected high whereas dropping to the targeted low would mean a gain of 29.13% for stock’s current value.
iBio Inc (IBIO) estimates and forecasts
This year revenue growth is estimated to rise 77.78% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 100k for the same. And 2 analysts are in estimates of company making revenue of 100k in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.55% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 60.55% while estimates for its earnings growth in next 5 years are of 45.01%.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders are in possession of 7.21% of company’s total shares while institution are holding 26.65 percent of that, with stock having share float percentage of 28.72%. Investors also watch the number of corporate investors in a company very closely, which is 26.65% institutions for iBio Inc that are currently holding shares of the company.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 73.14 shares of worth $0.37 million or 0.74% of the total outstanding shares. The later fund manager was in possession of 46.78 shares on Dec 31, 2024 , making its stake of worth around $0.24 million in the company or a holder of 0.47% of company’s stock.
